Epidemiology of hepatitis A in Greece in the last decade: management of reported cases and outbreaks and lessons learned.
Epidemiology
hepatitis A
outbreaks
public health
vaccination (immunisation)
Journal
Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737
Informations de publication
Date de publication:
13 02 2020
13 02 2020
Historique:
pubmed:
14
2
2020
medline:
17
7
2020
entrez:
14
2
2020
Statut:
epublish
Résumé
Hepatitis A is a mandatory notifiable disease in Greece. Here, we present the epidemiological data for 2009-2018 and the results of outbreak investigations performed, and discuss future public health priorities.Overall, 1193 cases were reported; 320 migrants/refugees, 240 Roma, 112 travellers and 521 from the general population. The median age of the affected general population (37 years) had an increasing trend (from 30.8 years in 2009 to 40.5 in 2018, P < 0.001) and was significantly higher than that among Roma and migrants (7 and 8 years, respectively, P < 0.001). Twenty-two cases (2.2%) were unvaccinated patients with a chronic liver disease. Fifty clusters with 2-12 cases each were recorded; 44 were attributed to person-to-person transmission and six to food consumption. Three outbreaks accounting for 32.3% of the total number of recorded cases were identified; in 2013 among Roma (112 cases), in 2016 among refugees (188 cases) and in 2017 among men having sex with men (96 cases; 33 of them (34.4%) HIV-positive). The epidemiological data depict that improving living conditions and vaccination coverage of deprived populations, and informing adults on the disease focusing at faecal-oral transmission during sexual intercourse and travel should be the future public health priorities.
Identifiants
pubmed: 32052723
doi: 10.1017/S0950268820000382
pii: S0950268820000382
pmc: PMC7078582
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e58Références
Hum Vaccin Immunother. 2015;11(1):192-7
pubmed: 25483535
Clin Infect Dis. 2001 Jan 15;32(2):297-9
pubmed: 11170922
Euro Surveill. 2011 Mar 03;16(9):
pubmed: 21392487
BMC Infect Dis. 2012 Jan 20;12:11
pubmed: 22264382
Eur J Public Health. 2017 Apr 1;27(2):318-324
pubmed: 27694159
Vaccine. 2012 Dec 17;31(1):3-11
pubmed: 22609026
Vaccine. 2012 Aug 10;30(37):5459-63
pubmed: 22776215
Eur J Epidemiol. 2016 Jul;31(7):711-4
pubmed: 27194123
Liver Int. 2016 Aug;36(8):1096-100
pubmed: 27187614
Emerg Microbes Infect. 2017 Apr 26;6(4):e26
pubmed: 28442750
J Infect Dis. 2003 Apr 15;187(8):1235-40
pubmed: 12696002
Vaccine. 2010 Sep 24;28(41):6653-7
pubmed: 20723630
Vaccine. 2011 Aug 26;29(37):6259-61
pubmed: 21763745
Euro Surveill. 2017 Jan 26;22(4):
pubmed: 28181904
J Med Microbiol. 2017 Mar;66(3):342-349
pubmed: 28086079
Euro Surveill. 2010 Jul 29;15(30):
pubmed: 20684816
J Infect. 2009 Jan;58(1):47-52
pubmed: 19059649
Prev Med Rep. 2018 Jun 20;11:139-144
pubmed: 30003012
Int J STD AIDS. 2015 Oct;26(12):852-6
pubmed: 25411352
Euro Surveill. 2017 Feb 2;22(5):
pubmed: 28183391
Health Secur. 2016 Jul-Aug;14(4):220-5
pubmed: 27362427
Euro Surveill. 2017 Feb 23;22(8):
pubmed: 28251892
Hum Vaccin Immunother. 2019;15(2):295-304
pubmed: 30111224
Avicenna J Med. 2018 Oct-Dec;8(4):147-152
pubmed: 30319956
Euro Surveill. 2018 May;23(22):
pubmed: 29871720
PLoS One. 2015 Jan 15;10(1):e0116939
pubmed: 25590132
World J Gastroenterol. 2017 May 28;23(20):3589-3606
pubmed: 28611512
Infection. 1987 Jul-Aug;15(4):221-7
pubmed: 3312019
Euro Surveill. 2018 Aug;23(33):
pubmed: 30131095